Enregistrement :
3
de
38
(2010-01-04
à
2011-02-02)
Politique ou Programme
Common Drug Review as it relates to reimbursement recommendations for decision-making process and framework.
Federal Public Drug Plans, with respect to the reimbursement of drug products for the Federal plan beneficiaries
Science and Technology Strategy, advocating for the development of a Biopharma sector in support of more research & development in Canada.
Politique ou Programme, Règlement
Subsequent Entry Biologics (SEBs): seeking an approval framework supported and protected by Regulations in harmonization with approaches taken by the European Union or the U.S. for instance.
Proposition législative, Projet de loi ou résolution
Bill C-6, Canada Consumer Product Safety Act with respect to creating a new system to regulate consumer products that pose, or might reasonably be expected to pose, a danger to human health and safety.
Food and Drugs Act & Regulations as it relates to Drug Export restriction and cross border trade.
Proposition législative, Projet de loi ou résolution, Règlement
The upcoming Food and Drugs Act Modernization legislative provisions (and Regulations) as it relates to improving the efficiency of the drug approval system.
Règlement
Patented Medicine Prices Review Board (PMPRB) Regulations as related to reporting requirements and pricing guidelines.
Patented Medicines (Notice of Compliance) Regulations as it relates to regulation of intellectual property for therapeutic products.